Training | 2015.04.22
Asymmetrex Interviewed in Anticipation of Presentations at the 14th Annual World Preclinical Congress Focused on Tackling Translation Challenges
In a recent interview, Asymmetrex, LLC founder and director James L. Sherley, M.D., Ph.D. talks about the company’s upcoming participation in forums to address “3D Models for Toxicological Research” at the 14th Annual World Preclinical Congress, scheduled from June 10-12 in Boston. Director Sherley relates how Asymmetrex’s unique approach to developing tissue stem cell technologies for drug development and stem cell medicine is the culmination of research that spans more than 20 years at three renowned research institutions.
(PRWeb April 22, 2015)
Read the full story at http://www.prweb.com/releases/2015/04/prweb12664810.htm
For more information, please visit
http://www.prweb.com/releases/2015/04/prweb12664810.htm
